secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-05-19T20:01:45+00:00
Accession:  0001193125-26-230711
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics converts all Series B Preferred Stock into 42.8M common shares
--------------------------------------------------------------------------------

- Converted 42,839.11 Series B preferred shares into 42,839,103 common shares on May 15, 2026.
- No fractional shares were issued; holders will receive cash in lieu of fractional shares.
- After conversion, no shares of Series B Preferred Stock remain outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/0001193125-26-230711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/d78370d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-230711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer